Wed 6/28/2017 15:08 ET
DJIA21461.30150.640.71%SOLAR20.000.241.21%GOLD1249.302.370.19%Shanghai3136.7734.501.10%
S&P 5002441.8322.710.93%BANKS24.500.371.51%OIL44.780.551.22%Nikkei20130.4194.610.47%
NASDAQ6231.8986.451.39%SEMI84.031.141.36%US/EU1.140.000.36%Futures2438.7518.250.75%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (Matachewan Cons Mines Ltd - MATN)    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add MATN
  
From: franconia (Rep: 102) reply to franconiaDate: 02/17/2017 12:56
Forum: Wall Street Pit - Msg #2661747 - List MATN msgs Thread #673880398 (Rec: 0)
Up almost 90% since last note 10 days ago. Good news begets price.
https://finance.yahoo.com/quote/matn?ltr=1

Re: MATN.. moving, some day this will be taken out or go parabolic.



Reply to franconia - Msg #3 - 10/31/2016 09:27

MATN.. moving, some day this will be taken out or go parabolic.

"“We believe these highly positive data generated for CA4P in combination with anti-angiogenic agents demonstrate the potential for CA4P to alter the treatment landscape for ovarian cancer, and they provide us with confidence as we move our program forward,” stated William D. Schwieterman, M.D., President and Chief Executive Officer of Mateon. “Our clinical investigators are excited to participate in the FOCUS Study, a phase 2/3 trial we initiated in June 2016, and we share their excitement as we look forward to the availability of key data from this study in the second half of 2017.”
What would you like to do? Message: Endorse | Bookmark | Report AbuseUser franconia: Reward | Watch | IgnoreMATN: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add MATN
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.